Cargando…

Drug-Eluting Stents in Multivessel Coronary Artery Disease: Cost Effectiveness and Clinical Outcomes

Multivessel coronary artery disease is more often treated either with coronary artery bypass surgery (CABG) or percutaneous coronary intervention (PCI) with stenting. The advent of drug-eluting stent (DES) has changed the revascularization strategy, and caused an increase in the use of DES in multiv...

Descripción completa

Detalles Bibliográficos
Autores principales:	Panchal, Kanaiya, Patel, Snehal, Bhatt, Parloop
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2012
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3533590/ https://www.ncbi.nlm.nih.gov/pubmed/23346105 http://dx.doi.org/10.1155/2012/679013

Ejemplares similares

Cost-effectiveness of percutaneous coronary intervention with drug-eluting stents in patients with multivessel coronary artery disease compared to coronary artery bypass surgery five-years after intervention
por: Krenn, Lisa, et al.
Publicado: (2014)

Drug-coated balloon-based versus drug-eluting stent-only revascularization in patients with diabetes and multivessel coronary artery disease
por: Her, Ae-Young, et al.
Publicado: (2023)

Coronary Artery Bypass Grafting vs. Drug-Eluting Stent Implantation for Multivessel Disease in Patients with Chronic Kidney Disease
por: Kang, Se Hun, et al.
Publicado: (2017)

Comparing mortality between coronary artery bypass grafting and percutaneous coronary intervention with drug-eluting stents in elderly with diabetes and multivessel coronary disease
por: Naito, Ryo, et al.
Publicado: (2015)

Outcomes of coronary artery bypass grafting versus percutaneous coronary intervention with second-generation drug-eluting stents for patients with multivessel and unprotected left main coronary artery disease
por: Papadopoulos, Kyriacos, et al.
Publicado: (2017)

Efficacy and safety of drug-eluting stenting compared with bypass grafting in diabetic patients with multivessel and/or left main coronary artery disease
por: Xin, Xiaojun, et al.
Publicado: (2019)

Clinical outcomes of patients with multivessel coronary artery disease treated with robot-assisted coronary artery bypass graft surgery versus one-stage percutaneous coronary intervention using drug-eluting stents
por: Su, Chieh-Shou, et al.
Publicado: (2019)

Second Generation Drug-Eluting Stent Implantation versus Coronary Artery Bypass Grafting in the Treatment of Young Patients with Left Main and/or Multivessel Coronary Disease
por: Chen, Xue, et al.
Publicado: (2020)

Long-Term Outcomes of Complete Versus Incomplete Revascularization for Patients with Multivessel Coronary Artery Disease and Left Ventricular Systolic Dysfunction in Drug-Eluting Stent Era
por: Sohn, Gwan Hyeop, et al.
Publicado: (2014)

Understanding the Outcome of Randomized Trials with Drug-Eluting Stents and Coronary Artery Bypass Graft in Patients with Multivessel Disease: A Review of a 25-Year Journey
por: Rodriguez, Alfredo E., et al.
Publicado: (2016)

Comparing mortality and myocardial infarction between coronary artery bypass grafting and drug-eluting stenting in patients with diabetes mellitus and multivessel coronary artery disease: a meta-analysis
por: Qi, Xiaolong, et al.
Publicado: (2014)

Comparison of long‐term clinical outcomes in multivessel coronary artery disease patients treated either with bioresoarbable polymer sirolimus‐eluting stent or permanent polymer everolimus‐eluting stent: 5‐year results of the CENTURY II randomized clinical trial
por: Iñiguez, Andrés, et al.
Publicado: (2019)

The stenting strategy of drug-eluting stents for coronary artery disease in patients on dialysis
por: Fujita, Hiroshi, et al.
Publicado: (2014)

Next-generation drug-eluting stents in coronary artery disease: focus on everolimus-eluting stent (Xience V(®))
por: Sheiban, Imad, et al.
Publicado: (2008)

Outcomes of stenting with overlapping drug-eluting stents versus overlapping drug-eluting and bare-metal stents for the treatment of diffuse coronary lesions
por: Kassaian, SE, et al.
Publicado: (2010)

Effectiveness of Percutaneous Coronary Intervention With Drug‐Eluting Stents Compared With Bypass Surgery in Diabetics With Multivessel Coronary Disease: Comprehensive Systematic Review and Meta‐analysis of Randomized Clinical Data
por: Hakeem, Abdul, et al.
Publicado: (2013)

Widowmaker Right Coronary Artery Treated With Drug-Eluting Stent Implantation
por: Singh, Gurpreet, et al.
Publicado: (2019)

Drug-eluting coronary stents – focus on improved patient outcomes
por: Jaffery, Zehra, et al.
Publicado: (2011)

Impact of stent length and diameter on short term clinical outcomes of drug eluting stents in patients with stable coronary artery disease
por: Adnan, Yasir, et al.
Publicado: (2017)

Drug-eluting stents vs. coronary artery bypass-grafting in coronary heart disease
por: Gorenoi, Vitali, et al.
Publicado: (2008)

Two-year Clinical Outcomes of Patients with Long Segments Drug-Eluting Stents: Comparison of Sirolimus-Eluting Stent with Paclitaxel-Eluting Stent
por: Kim, Ung, et al.
Publicado: (2011)

Drug-Eluting Stent as an Option for Intractable In-Stent Coronary Restenosis
por: Hachinohe, Daisuke, et al.
Publicado: (2011)

Multivessel Coronary Artery Vasospasm-Induced Takotsubo Cardiomyopathy
por: Patel, Vishal I., et al.
Publicado: (2022)

Comparison of Drug-eluting Coronary Stents, Bare Coronary Stents and Self-expanding Stents in Angioplasty of Middle Cerebral Artery Stenoses
por: Lee, Jong-Hyeog, et al.
Publicado: (2013)

Switching types of drug-eluting stents does not prevent repeated in-stent restenosis in patients with coronary drug-eluting stent restenosis
por: Nojima, Yuhei, et al.
Publicado: (2014)

Comparison of drug-eluting balloon with repeat drug-eluting stent for recurrent drug-eluting stent in-stent restenosis
por: Wang, Guozhong, et al.
Publicado: (2019)

Coronary Artery Aneurysm after Second-Generation Drug-Eluting Stent Implantation
por: Hong, Sung-Jin, et al.
Publicado: (2019)

Coronary artery perforation successfully treated with a second drug-eluting stent
por: Strycek, Matej, et al.
Publicado: (2023)

Bare metal stents, durable polymer drug eluting stents, and biodegradable polymer drug eluting stents for coronary artery disease: mixed treatment comparison meta-analysis
por: Bangalore, Sripal, et al.
Publicado: (2013)

Multivessel Woven Coronary Artery Disease
por: Dallan, Luis Roberto Palma, et al.
Publicado: (2021)

Extended Outcomes of Complex Coronary Disease in the Drug Eluting Stent Era
por: Desrosiers, Kevin P., et al.
Publicado: (2011)

Coronary Artery Aneurysm After Drug-Eluting Stent Implantation Causing Coronary-Bronchial Fistula
por: Gupta, Ankush, et al.
Publicado: (2020)

Drug eluting stents: Focus on Cypher™ sirolimus-eluting coronary stents in the treatment of patients with bifurcation lesions
por: Chieffo, Alaide, et al.
Publicado: (2007)

Case series of coronary artery aneurysms after Everolimus eluting stent implantation and comparison with Sirolimus eluting stents
por: Sharma, Raghav, et al.
Publicado: (2022)

Cost-effectiveness of drug-eluting stents versus bare-metal stents in patients undergoing percutaneous coronary intervention
por: Baschet, Louise, et al.
Publicado: (2016)

Drug- and Gene-eluting Stents for Preventing Coronary Restenosis
por: Lekshmi, Kamali Manickavasagam, et al.
Publicado: (2017)

Everolimus-eluting coronary stents
por: Saez, Alejandro, et al.
Publicado: (2010)

Acute coronary syndromes and multivessel coronary artery disease
por: Zimbardo, Giuseppe, et al.
Publicado: (2023)

Being a clinical pharmacist: Expectations and outcomes
por: Bhatt, Parloop A.
Publicado: (2014)

Prevention of the renarrowing of coronary arteries using drug-eluting stents in the perioperative period: an update
por: Llau, Juan V, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_paq44h07nio02plc2egghkdbht